http://drugtopics.modernmedicine.co...detail/774862?contextCategoryId=47443&ref=25
Choudhry and colleagues studied a large group of managed-care enrollees starting oral diabetes treatment and found that 35% of patients did not receive the recommended first-line drug. Further, the medication costs for this subgroup of patients comprised 66.3% of the total expenditures for hypoglycemic drugs in the entire cohort.
A short piece that maybe reaffirms suspicions of expediency. 8)
Choudhry and colleagues studied a large group of managed-care enrollees starting oral diabetes treatment and found that 35% of patients did not receive the recommended first-line drug. Further, the medication costs for this subgroup of patients comprised 66.3% of the total expenditures for hypoglycemic drugs in the entire cohort.
A short piece that maybe reaffirms suspicions of expediency. 8)
